International Assets Investment Management’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $186K | Hold |
48,640
| – | – | 0.02% | 776 |
|
|
2025
Q1 | $280K | Sell |
48,640
-11,110
| -19% | -$63.9K | 0.02% | 594 |
|
|
2024
Q4 | $312K | Sell |
59,750
-227,537
| -79% | -$1.19M | 0.03% | 555 |
|
|
2024
Q3 | $53.3K | Buy |
287,287
+229,487
| +397% | +$42.6K | 0.15% | 141 |
|
|
2024
Q2 | $191K | Sell |
57,800
-2,500
| -4% | -$8.28K | 0.02% | 732 |
|
|
2024
Q1 | $197K | Buy |
60,300
+1,800
| +3% | +$5.89K | 0.02% | 686 |
|
|
2023
Q4 | $205K | Buy |
58,500
+9,518
| +19% | +$33.4K | 0.03% | 628 |
|
|
2023
Q3 | $299K | Buy |
48,982
+695
| +1% | +$4.25K | 0.04% | 374 |
|
|
2023
Q2 | $405K | Sell |
48,287
-19,105
| -28% | -$160K | 0.05% | 316 |
|
|
2023
Q1 | $669K | Buy |
67,392
+4,585
| +7% | +$45.5K | 0.1% | 210 |
|
|
2022
Q4 | $437K | Buy |
62,807
+3,530
| +6% | +$24.6K | 0.05% | 376 |
|
|
2022
Q3 | $317K | Sell |
59,277
-598
| -1% | -$3.2K | 0.07% | 271 |
|
|
2022
Q2 | $239 | Buy |
59,875
+2,750
| +5% | +$11 | 0.02% | 344 |
|
|
2022
Q1 | $254K | Buy |
57,125
+6,800
| +14% | +$30.2K | 0.05% | 361 |
|
|
2021
Q4 | $201K | Buy |
50,325
+8,125
| +19% | +$32.5K | 0.04% | 463 |
|
|
2021
Q3 | $371K | Buy |
42,200
+14,925
| +55% | +$131K | 0.07% | 293 |
|
|
2021
Q2 | $309K | Sell |
27,275
-10,080
| -27% | -$114K | 0.06% | 329 |
|
|
2021
Q1 | $306K | Buy |
37,355
+10,040
| +37% | +$82.2K | 0.03% | 431 |
|
|
2020
Q4 | $187K | Buy |
+27,315
| New | +$187K | 0.03% | 390 |
|